» Articles » PMID: 1829693

Macrophage Cytotoxicity Towards Isolated Rat Islet Cells: Neither Lysis nor Its Protection by Nicotinamide Are Beta-cell Specific

Overview
Journal Diabetologia
Specialty Endocrinology
Date 1991 Apr 1
PMID 1829693
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

In animal models of Type 1 (insulin-dependent) diabetes mellitus macrophages were shown to be the first immunocytes that infiltrate the pancreatic Langerhans islets in the autoimmune process. We now show direct macrophage cytotoxicity against isolated rat islet cells in an electron microscopical study, which permits investigation of the specificity of this process. Freshly isolated islet cells were co-incubated with syngeneic peritoneal macrophages at a target: effector-cell ratio of 1:2. After various time periods, the cells were directly fixed and embedded; the ratio of live and dead cells was evaluated by electron microscopy. Our results demonstrate that activated but not resident macrophages lyse islet cells in a time-dependent manner. After 15 h of co-incubation lysis of islet cells is complete. No islet cell-macrophage contacts and no differences between the lysis of Beta cells or non-Beta cells were observed during the observation period. Islet cells encapsulated in alginate were also lysed by macrophages as a direct proof for soluble mediator(s) of cytotoxicity. Nicotinamide protected islet cells from lysis in a dose-dependent manner. As a result of this electron microscopic study we conclude that even at very low target: effector ratios, activated macrophages lyse syngeneic islet cells regardless of islet cell type via secretion of humoral mediator(s).

Citing Articles

Uncoupling protein-2 increases nitric oxide production and TNFAIP3 pathway activation in pancreatic islets.

Nino Fong R, Fatehi-Hassanabad Z, Lee S, Lu H, Wheeler M, Chan C J Mol Endocrinol. 2011; 46(3):193-204.

PMID: 21321094 PMC: 3077812. DOI: 10.1530/JME-10-0117.


Nitric oxide and peroxynitrite in health and disease.

Pacher P, Beckman J, Liaudet L Physiol Rev. 2007; 87(1):315-424.

PMID: 17237348 PMC: 2248324. DOI: 10.1152/physrev.00029.2006.


The role of interleukin-1 in the pathogenesis of IDDM.

Mandrup-Poulsen T Diabetologia. 1996; 39(9):1005-29.

PMID: 8877284 DOI: 10.1007/BF00400649.


The immunologic insult in type 1 diabetes.

Honeyman M, Harrison L Springer Semin Immunopathol. 1993; 14(3):253-74.

PMID: 8438209 DOI: 10.1007/BF00195977.


Protection of islet cells from inflammatory cell death in vitro.

Burkart V, Kolb H Clin Exp Immunol. 1993; 93(2):273-8.

PMID: 8348756 PMC: 1554829. DOI: 10.1111/j.1365-2249.1993.tb07979.x.


References
1.
Stauffacher W, Burr I, Gutzeit A, Beaven D, Veleminsky J, Renold A . Streptozotocin diabetes: time course of irreversible B-cell damage; further observations on prevention by nicotinamide. Proc Soc Exp Biol Med. 1970; 133(1):194-200. DOI: 10.3181/00379727-133-34439. View

2.
Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello C, Svenson M, Nielsen J . Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia. 1986; 29(1):63-7. DOI: 10.1007/BF02427283. View

3.
Keller R, Keist R, Groscurth P . Firm persistent binding between activated macrophages and tumor cells is not a prerequisite for the mediation of cytolysis. Int J Cancer. 1986; 37(1):89-95. DOI: 10.1002/ijc.2910370115. View

4.
Spurr A . A low-viscosity epoxy resin embedding medium for electron microscopy. J Ultrastruct Res. 1969; 26(1):31-43. DOI: 10.1016/s0022-5320(69)90033-1. View

5.
Smidsrod O, Skjak-Braek G . Alginate as immobilization matrix for cells. Trends Biotechnol. 1990; 8(3):71-8. DOI: 10.1016/0167-7799(90)90139-o. View